Azusa Saika - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Azusa Saika

Showing results (51-60 of 53) with videos related to

Pageof 6

Sort By:

You have reached the last page of results.This site can display upto 53 results.

Journal of the American Chemical Society|January 10, 2024

Linkage-Editing Pseudo-Glycans: A Reductive α-Fluorovinyl-<i>C</i>-Glycosylation Strategy to Create Glycan Analogs with Altered Biological ActivitiesTakahiro Moriyama, Makoto Yoritate, Naoki Kato, et al.

Nature Communications|August 18, 2022

Oral administration of Blautia wexlerae ameliorates obesity and type 2 diabetes via metabolic remodeling of the gut microbiotaKoji Hosomi, Mayu Saito, Jonguk Park, et al.

Mucosal Immunology|January 11, 2022

Intestinal microbe-dependent ω3 lipid metabolite αKetoA prevents inflammatory diseases in mice and cynomolgus macaquesTakahiro Nagatake, Shigenobu Kishino, Emiko Urano, et al.

Pageof 6

Search research articles

Showing results (51-60 of 53) with videos related to

Sort By:

Pageof 6

You have reached the last page of results.This site can display upto 53 results.

Journal of the American Chemical Society|January 10, 2024

Nature Communications|August 18, 2022

Oral administration of Blautia wexlerae ameliorates obesity and type 2 diabetes via metabolic remodeling of the gut microbiotaKoji Hosomi, Mayu Saito, Jonguk Park, et al.

Mucosal Immunology|January 11, 2022

Intestinal microbe-dependent ω3 lipid metabolite αKetoA prevents inflammatory diseases in mice and cynomolgus macaquesTakahiro Nagatake, Shigenobu Kishino, Emiko Urano, et al.

Pageof 6